Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects

Transfusion

Volumn 30, Issue 4, 1990, Pages 344-357

  Polesky, H F ^b  

^a Memorial Blood Centers of Minnesota   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD GROUP; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ADULT; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; INCIDENCE; PREGNANCY; RISK FACTORS; TIME FACTORS;

EID: 0025291846     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1990.30490273444.x     Document Type: Review

References (118)

1. Anaemia from bleeding of the fetus into the mother's circulation
2. Demonstration of fetal hemoglobin in erythrocytes of a blood smear
3. Transplacental passage of fetal erythrocytes during pregnancy
4. Demonstration of fetal erythrocytes in maternal circulation
5. Association between foeto‐maternal bleeding and hypertension in pregnancy
6. Feto maternal haemorrhage in ectopic pregnancy
7. Transplacental haemorrhage
8. The transplacental passage of foetal red blood‐cells and the pathogenesis of Rh immunisation during pregnancy
9. Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies
10. Rh‐immunization by pregnancy: results of a survey and their relevance to prophylactic therapy
11. Detection of fetal erythrocytes in maternal blood post partum with the fluorescence‐activated cell sorter
12. The pathogenesis and prevention of Rh immunization
13. Foetal erythrocytes in maternal blood and immunoprophylaxis of Rh‐immunization. Clinical and experimental studies
14. Prevention of rhesus immunization. A controlled clinical trial with a comparatively low dose of anti‐D immunoglobulin
15. Observation of compatible and incompatible foetal red cells in the maternal circulation
16. Results of Rh‐sensitization prophylaxis and research into standardization of immunoglobulin‐anti‐D
17. The identification of the high‐risk patient in Rhesus sensitization by the use of post‐partum foetal cell counts
18. Transplacental fetal‐maternal hemorrhage
19. Relationship of transplacental hemorrhage to abnormal pregnancy and delivery
20. Report to the Medical Research Council by the working party on the use of anti‐D‐immunoglobulin for the prevention of isoimmunization of Rh‐negative women during pregnancy
21. Intrapartum fetomaternal bleeding in Rh‐negative women
22. Estimation of feto‐maternal hemorrhage after delivery with a view to the prevention of anti‐D immunization. Results of 5488 Kleihauer tests
23. Counting fetal erythrocytes as a diagnostic aid in perinatal death and morbidity
24. Relevancy in the selection of serologic tests for the obstetric patient
25. Practical use of the demonstration of cells containing hemoglobin F in fixed blood smears
26. Semi‐quantitative estimation of the distribution of fetal hemoglobin in red cell populations
27. Fetales Hämoglobin und fetale Erythrozyten
28. Fetomaternal hemorrhage‐incidence and methods of detection and quantitation
29. Fetomaternal transfusion following trauma
30. Haemoglobin‐F: serological conditions and occurrence in normal adults and normal pregnant and post partum women with particular reference to foeto‐maternal haemorrhage
31. Prepartum diagnosis of traumatic fetal‐maternal hemorrhage
32. Massive feto‐maternal hemorrhage as a cause of perinatal mortality and morbidity
33. Fetomaternal hemorrhage following trauma
34. Fetomaternal transfusion at placental puncture (letter)
35. Transplacental fetal hemorrhage after amniocentesis
36. Fetal hemorrhage associated with amniocentesis
37. Fetomaternal hemorrhage from diagnostic transabdominal amniocentesis
38. Transplacental foetal haemorrhage after placental injury during delivery or amniocentesis
39. Transplacental haemorrhage after external cephalic version
40. Massive chronic feto‐maternal bleeding associated with placental chorioangiomas
41. Transplacental hemorrhage associated with placental neoplasms
42. Placental chorioangioma: a rare cause of fetomaternal transfusion with maternal hemolysis and fetal distress
43. Massive fetomaternal hemorrhage due to chorio‐carcinoma of the uterus (letter)
44. Severe fetomaternal hemorrhage. A report of four cases
45. Nonimmunologic hydrops fetalis. Report of two cases
46. Incompatible fetomaternal transfusion with maternal intravascular lysis
47. Ultrasound diagnosis of abruptio placentae with fetomaternal hemorrhage
48. Monoamniotic twin pregnancy complicated by massive fetal‐maternal haemorrhage
49. Clinical high‐risk designation does not predict excess fetal‐maternal hemorrhage
50. Feto‐maternal haemorrhage as a cause of fetal morbidity and mortality
51. Hypovolemic shock at birth due to extensive fetomaternal hemorrhage
52. Detection of transplacental hemorrhage during the last trimester of pregnancy (letter)
53. Occult fetomaternal haemorrhage as a cause of fetal mortality and morbidity
54. Risk factors for fetomaternal hemorrhage of a volume necessitating more than a standard dose of Rh immune globulin (abstract)
55. The quantitative estimation of foetal erythrocytes in maternal blood
56. Fetal exsanguination after amniocentesis
57. Amniocentesis and fetal‐maternal blood transfusion: a review of the literature
58. Risks of fetomaternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization
59. Massive fetal‐maternal hemorrhage: an overlooked cause of perinatal morbidity and mortality (abstract)
60. A case of hydrops foetalis due to foeto‐maternal haemorrhage
61. Signifance of placental pathology in transplancental haemorrhage
62. The fetus can bleed. Three clinicopathological pictures
63. Transplacental haemorrhage and maternal isoimmunization
64. Transplacental hemorrhage in postterm pregnancies
65. Clinical high risk designation does not predict excess fetal‐maternal hemorrhage (abstract)
66. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh‐negative women
67. Tests to detect and quantitate fetomaternal bleeding
68. Fetomaternal bleeding during attempts at external version
69. Fetomaternal bleeding as a cause for “unexplained” fetal death
70. [Fetomaternal hemorrhages and their importance in perinatal pathology] (Eng abstract)
71. Transplacental hemorrhage
72. o (D) gamma globulin
73. Obstetric determinants of rhesus sensitisation
74. Transplacental passage of fetal red cells into the maternal circulation. In normal, abnormal, and instrumental deliveries
75. Transplacental hemorrhage in cesarean section
76. o (D) immune globulin (human)
77. 2 indicator erythrocytes
78. o (D)‐positive cells in whole blood (abstract)
79. Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme‐linked antiglobulin test
80. Quantitation of fetal‐maternal hemorrhage by flow cytometry. A simple and accurate method
81. Posthemorrhagic anemia and shock in the newborn: A review
82. Chronic massive fetomaternal hemorrhage: a case report
83. Blood hemoglobin levels in the neonatal period
84. A method of measuring the severity of a series of cases of hemolytic disease of the newborn
85. Massive transplacental hemorrhage: clinical manifestations in the newborn
86. Placental transfusion
87. Red cell and plasma volume in newborn infants
88. Transplacental bleeding from the foetus
89. Iron‐deficiency anemia at birth. Two examples secondary to chronic fetal‐maternal hemorrhage
90. Fetomaternal transfusion
91. Studies on the nucleated red cell count in the chorionic capillaries and the cord blood of various ages of pregnancy
92. Failure of anti‐D immuno‐globulin to protect against Rhesus immunization after massive foeto‐maternal haemorrhage. Report of 4 cases
93. Prevention of Rh immunization after massive Rh‐positive transfusion
94. Transplacental transmission of fetal erythrocytes
95. Life‐span of the fetal red blood cell
96. The distribution of fetal hemoglobin in the blood of normal children and adults
97. Self‐limited hemolytic transfusion reaction in an ABO‐incompatible maternal‐fetal unit
98. Fetomaternal ABO incompatibility: intravascular hemolysis, fetal hemoglobinemia, and fibrinogenopenia in maternal circulation
99. Acute renal failure after haemolysis, probably due to foeto‐maternal transfusion
100. Mechanisms of isoimmunization. II. Transplacental passage and postnatal survival of fetal erythrocytes in heterospecific pregnancies
101. Number of B sites generated on group O red cells from adults and newborn infants
102. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti‐A antibodies by infant (cord) red cells